← back to search

Lian Jiang

Hebei Medical University · CN
Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Neutropenia and Cancer Infections, and CNS Lymphoma Diagnosis and Treatment.
h-index
2
citations
12
works
12
NIH funding
primary concept
email

Recent publications

Clinical features, mutational landscape and their prognostic impact in Chinese paediatric patients with T‐cell lymphoblastic lymphoma
British Journal of Haematology 2025cited by 1position: middledoi
Clinical characteristics and treatment evaluation of T-cell lymphoblastic lymphoma in Chinese children and adolescents:a multicenter clinical study of China-net childhood lymphoma-lbl-2017
Blood 2025cited by 0position: middledoi
Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study
Frontiers in Pharmacology 2024cited by 3position: middledoi
A multicenter phase <scp>II</scp> trial of primary prophylactic <scp>PEG‐rhG‐CSF</scp> in pediatric patients with solid tumors and <scp>non‐Hodgkin</scp> lymphoma after chemotherapy: An interim analysis
Cancer Medicine 2023cited by 4position: middledoi
Clinical Features and Therapeutic Evaluation of Central Nervous System Involvement in Pediatric Anaplastic Large Cell Lymphoma
Blood 2023cited by 1position: middledoi
Clinical Pathology Characteristics of 221 Pediatric Anaplastic Large Cell Lymphoma-3 Years Follow up and Experience from China Net Childhood Lymphoma(CNCL)
Blood 2023cited by 0position: middledoi
Screening and identification of novel candidate biomarkers of focal cortical dysplasia type II via bioinformatics analysis
Child s Nervous System 2022cited by 2position: lastdoi
Predictive value of combining maternal peripheral blood count indicators for early-onset sepsis in preterm infants: A retrospective cohort study
Medicine 2022cited by 1position: middledoi
Results of the Neuroblastoma-2015 protocol for treating neuroblastoma in China: experience from multiple centers
2020cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiangling He · Sun Yat-sen University Cancer Center2 papers (2023–2024)Yan‐Lai Tang · Sun Yat-sen University2 papers (2023–2024)Suying Lü · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2023–2024)Junting Huang · Shanghai Jiao Tong University2 papers (2023–2024)Lihua Yang · Yale Cancer Center2 papers (2024–2025)Yunpeng Dai · Shandong University2 papers (2020–2025)Yanpeng Wu · Fudan University2 papers (2023–2024) · 1 papers (2025–2025)Xiheng Lin · Guangzhou Medical University1 papers (2024–2024)Mincui Zheng · Sun Yat-sen University Cancer Center1 papers (2025–2025)Yun Liu · Kunming Children's Hospital1 papers (2020–2020)Qiang Zhao · Shanxi Medical University1 papers (2020–2020)Runming Jin · Union Hospital1 papers (2025–2025)Feifei Sun · Qingdao University1 papers (2023–2023)Xue‐Qun Luo · Sun Yat-sen University1 papers (2023–2023)Chuan Tian · Oregon State University1 papers (2024–2024)Keyan Yang · Shandong University of Technology1 papers (2025–2025)Jiangya Wang · Hebei General Hospital1 papers (2022–2022)Hui Gao · Anhui Medical University1 papers (2025–2025)Jia Zhu · Sun Yat-sen University1 papers (2023–2023)